Proprietary

Our Si-quat molecules are protected by 3 unique patent families with 23 pending applications.

Wholly-owned

Our protections include 4 pending U.S. patent applications, 1 international patent application, and 14 foreign filed applications.

Protected IP

We have worked to aggressively protect our IP internationally in major markets, including Europe, China, and Japan.

About Research

Reliable Agroscience & Soil Analysis Research.

At Topikos, we recognize antibiotic and antifungal resistance is rising to one of the largest issues facing society today. This is highlighted by the increase in previously preventable antimicrobial deaths. Topikos has a portfolio of topical devices and products that treat or disrupt hard to treat infections, and allows the patients’ immune systems a better chance to successfully fight infections.

Medical Research

Medical research refers to the systematic investigation and study of various aspects of medicine and healthcare

Blood Resources

Blood resources refer to the collection, processing, and distribution of blood and blood products, including red blood cells, plasma, and platelets.

Laboratory Services

Reliable & High-Quality
Laboratory Service

  • Molecular Testing
  • Testing for Traces
  • Microbiology Tests
  • Biochemistry Tests
  • Histopatology Tests

Molecular Testing

quasi architebeat vitae dicta sunt explicabo nemo enim ipsam volup tatem quia voluptassit aspernatur aut odit fugit sed quia consequuntur magni dolores eos qui ratione voluptam sequi nescuntneque porro quisquam.

  • The Mycobacteriology Section
  • The Aerobic Bacteriology Section
Our Services

Molecular Testing

quasi architebeat vitae dicta sunt explicabo nemo enim ipsam volup tatem quia voluptassit aspernatur aut odit fugit sed quia consequuntur magni dolores eos qui ratione voluptam sequi nescuntneque porro quisquam.

  • The Mycobacteriology Section
  • The Aerobic Bacteriology Section
Our Services

Molecular Testing

quasi architebeat vitae dicta sunt explicabo nemo enim ipsam volup tatem quia voluptassit aspernatur aut odit fugit sed quia consequuntur magni dolores eos qui ratione voluptam sequi nescuntneque porro quisquam.

  • The Mycobacteriology Section
  • The Aerobic Bacteriology Section
Our Services

Molecular Testing

quasi architebeat vitae dicta sunt explicabo nemo enim ipsam volup tatem quia voluptassit aspernatur aut odit fugit sed quia consequuntur magni dolores eos qui ratione voluptam sequi nescuntneque porro quisquam.

  • The Mycobacteriology Section
  • The Aerobic Bacteriology Section
Our Services

Molecular Testing

quasi architebeat vitae dicta sunt explicabo nemo enim ipsam volup tatem quia voluptassit aspernatur aut odit fugit sed quia consequuntur magni dolores eos qui ratione voluptam sequi nescuntneque porro quisquam.

  • The Mycobacteriology Section
  • The Aerobic Bacteriology Section
Our Services
Topikos Creates Solutions

Well Ensure You Always Get The Best Results.

First-in-Human Topical Fungicide

existing antifungals are slow-acting, only inhibit growth

Effective Treatment of Biofilms

leading cause of Superbug Spread

Topikos Creates Solutions

First-in-Human Topical Fungicide

Existing antifungals are slow-acting, only inhibit growth.


Effective Treatment of Biofilms

Leading cause of Superbug Spread.

Biofilms causing infection, decay, contamination, and spoilage are estimated to cost $5 Trillion per year across multiple sectors.

Our breakthrough treatments to remove biofilms are coming to market starting in 2023.

Our ambitions are to displace failing and toxic products with a pipeline full of safe, effective antibiofilm remedies with no harmful side effects.

Testimonials

What Our Patient Say?

Team Member

Focusing Your Mind, with The
Best Expert.

William Cast, MD

CEO AND PRESIDENT

Carl Hilliard, JD

COO AND SECRETARY
Clinical Services

Laboratory Priority Services Delivered
We Have Great Skills

0+
Permanent Staff
0k+
Test Completed
0+
Wining Awards
0k+
Years Of Exps.
Recent Article

Interesting Articles Updated
Every Daily

Become An Invested Partner

Contact Us